MYB and neoplasm: Accordingly, we first propose the dual role for NICD1 in SACC, as follows: ATRA-induced upregulation of NICD1 and downregulation of MYB or MYC through RARα alters SACC cell fate differentiation and further inhibits tumor cell malignant progression.